Abstract
Government declares 'national shortage' of GLP-1 receptor agonists for type 2 diabetes until 2024
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have